Niemann Pick C1 mistargeting disrupts lysosomal cholesterol homeostasis contributing to neurodegeneration in a Batten disease model
Science Advances · 2025
DOI: 10.1126/sciadv.adr5703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Abhilash P Appu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section on Developmental Genetics, Division of Translational Medicine, Eunice Kennedy-Shriver National Institute of Child Health and Human Developmen…. Hauptthemen laut MEDLINE: Lysosomes, Cholesterol, Niemann-Pick C1 Protein, Homeostasis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Neurodegeneration is a devastating manifestation in most lysosomal storage disorders (LSDs). Loss-of-function mutations in CLN1 , encoding palmitoyl-protein thioesterase-1 (PPT1), cause CLN1 disease, a devastating neurodegenerative LSD that has no curative treatment. Numerous proteins in the brain require dynamic S-palmitoylation (palmitoylation-depalmitoylation) for trafficking to their destination. Although PPT1 depalmitoylates S-palmitoylated proteins and its deficiency causes CLN1 disease, the underlying pathogenic mechanism has remained elusive. We report that Niemann-Pick C1 (NPC1), a polytopic membrane protein mediating lysosomal cholesterol egress, requires dynamic S-palmitoylation for trafficking to the lysosome. In Cln1 −/− mice, Ppt1 deficiency misroutes NPC1-dysregulating lysosomal cholesterol homeostasis. Along with this defect, increased oxysterol-binding protein (OSBP) promotes cholesterol-mediated activation of mechanistic target of rapamycin C1 (mTORC1), which inhibits autophagy contributing to neurodegeneration. Pharmacological inhibition of OSBP suppresses mTORC1 activation, rescues autophagy, and ameliorates neuropathology in Cln1 −/− mice. Our findings reveal a previously unrecognized role of CLN1 /PPT1 in lysosomal cholesterol homeostasis and suggest that suppression of mTORC1 activation may be beneficial for CLN1 disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section on Developmental Genetics, Division of Translational Medicine, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1830, USA.
- Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1830, USA.
- Biostatistics and Bioinformatics Branch (HNT72), Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1830, USA.
ORCID-Profile: Abhilash P Appu, Maria B Bagh, Avisek Mondal, Anil B Mukherjee
Zitieren
APA
Appu, A. P., Bagh, M. B., Plavelil, N., Mondal, A., Sadhukhan, T., Singh, S. P., Perkins, N. J., Liu, A., & Mukherjee, A. B. (2025). Niemann Pick C1 mistargeting disrupts lysosomal cholesterol homeostasis contributing to neurodegeneration in a Batten disease model. Science Advances. https://doi.org/10.1126/sciadv.adr5703
Vancouver
Appu AP, Bagh MB, Plavelil N, Mondal A, Sadhukhan T, Singh SP, et al. Niemann Pick C1 mistargeting disrupts lysosomal cholesterol homeostasis contributing to neurodegeneration in a Batten disease model. Science Advances. 2025. doi:10.1126/sciadv.adr5703
BibTeX
@article{Appu2025,
author = {Appu, Abhilash P and Bagh, Maria B and Plavelil, Nisha and Mondal, Avisek and Sadhukhan, Tamal and Singh, Satya P and Perkins, Neil J and Liu, Aiyi and Mukherjee, Anil B},
title = {Niemann Pick C1 mistargeting disrupts lysosomal cholesterol homeostasis contributing to neurodegeneration in a Batten disease model},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr5703}
}
EUVIMED